Anticalin Proteins as Key Components in Advanced Multispecific Formats

Time: 11:30 am
day: Focus Day Track A - AM


  • Serving robust and highly precise building blocks for target binding in therapeutic bi- and multispecific formats
  • Precision targeting and receptor engagement in immuno-oncology can be realized by IgG-Anticalin fusion proteins tailored to the biologic situation
  • Monospecific Anticalin and bispecific Duocalin proteins for inhibition of TNF superfamily receptors in therapy of autoimmune diseases can be endowed with half-life extending modules binding to serum proteins